Sign in

CIK 0001650664

  • Non-accelerated filer
  • Smaller reporting company

Editas Medicine, Inc.

Sign in to watch
Ticker
EDIT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464097528
Phone
+1 617-401-9000
Business address
11 HURLEY ST., CAMBRIDGE, MA, 02141
  1. 3 Insider Initial Statement of Ownership
  2. 4 Planned sale SVP, CHIEF MEDICAL OFFICER sold 4,317 shares at $8.80 ($37,990)
  3. 4 Planned sale CEO sold 6,486 shares at $9.50 ($61,638)
  4. 4 Planned sale EVP, CBO AND CTO sold 105 shares at $9.50 ($998)
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Grant or award EVP, CHIEF FINANCIAL OFFICER acquired 77,900 shares (grant or award)
  13. 3 Insider Initial Statement of Ownership
  14. 4 Planned sale EVP, CHIEF FINANCIAL OFFICER sold 949 shares at $9.87 ($9,369)
  15. 4 Planned sale EVP, CBO AND CTO sold 668 shares at $9.87 ($6,594)
  16. 4 Planned sale EVP, CBO AND CTO sold 135 shares at $9.51 ($1,284)
  17. 4 Derivatives Options or other derivatives
  18. 3 Insider Initial Statement of Ownership
  19. 4 Open-market sale EVP, CHIEF FINANCIAL OFFICER sold 184 shares at $8.89 ($1,636)
  20. 4 Grant or award SVP, CHIEF MEDICAL OFFICER acquired 18,000 shares (grant or award)

Page 5 of 18 · 351 filings